Karin Tarte, PhD1*, Jean-jacques Lataillade, MD, PhD2*, Loïc Fouillard, MD, PhD3*, Julien Gaillard4*, Martine Becker, MD5*, Delphine Monnier, PhD1*, Helene Rouard, PhD6*, Andrei Tchirkov, MD, PhD7*, Jean-Paul Vernant, Pr8*, Norbert C Gorin, Pr9, Patrick Gourmelon, Pr10* and Luc Sensebe, MD, PhD11*
1Inserm U917-MICA, Faculté de Médecine de Rennes, Rennes, France
2CTSA, Clamart, France
3Hematology, AP-HP Hopital Saint-Antoine, Paris, France
4Research department, EFS Centre Atlantique & EA3855, Tours, France
5Futurebiolab, Genève, Switzerland
6Thérapie Cellulaire, EFS Ile de France, Créteil, France
7Service de Cytogénétique Médicale, CHU de Clermont-Ferrand and EA3846, Clermont-Ferrand, France
8Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, Paris, France
9Hematology-Oncology, Hopital Saint-Antoine and Universite Pierre et Marie Curie UPMC, Paris, France
10IRSN, France
11Research department, EFS Centre Atlantique & EA3855, 37000 Tours, France